
Commentary|Videos|April 23, 2026
COA 2026: Turning Policy Into Practice: Why Advocacy Matters in Community Oncology
Advertisement
In this Community Oncology Alliance (COA) pre-conference interview with Pharmacy Times, Nick Ferreyros discusses the importance of making health policy relevant by connecting it directly to patient care and clinical practice. He highlights new data from collaboration with Flatiron Health showing strong outcomes in community oncology, helping to challenge outdated perceptions. Ferreyros also warns of key policy threats, including the Inflation Reduction Act, and ongoing challenges with pharmacy benefit managers that may impact care delivery. He emphasizes that provider advocacy is essential to driving change and protecting access to care. You can view more coverage from COA
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5



































































































